DK638389A - Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne - Google Patents

Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne Download PDF

Info

Publication number
DK638389A
DK638389A DK638389A DK638389A DK638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A
Authority
DK
Denmark
Prior art keywords
echariotic
beta2
precautions
codes
procedures
Prior art date
Application number
DK638389A
Other languages
English (en)
Other versions
DK638389D0 (da
Inventor
Anthony F Purchio
Linda Madisen
Nancy Webb
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK638389D0 publication Critical patent/DK638389D0/da
Publication of DK638389A publication Critical patent/DK638389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK638389A 1988-12-16 1989-12-15 Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne DK638389A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28514088A 1988-12-16 1988-12-16
US07/446,020 US5221620A (en) 1987-10-06 1989-12-05 Cloning and expression of transforming growth factor β2

Publications (2)

Publication Number Publication Date
DK638389D0 DK638389D0 (da) 1989-12-15
DK638389A true DK638389A (da) 1990-06-17

Family

ID=26963007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK638389A DK638389A (da) 1988-12-16 1989-12-15 Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne

Country Status (8)

Country Link
US (1) US5221620A (da)
EP (2) EP0676474A1 (da)
CN (1) CN1045992A (da)
AU (1) AU640115B2 (da)
DK (1) DK638389A (da)
FI (1) FI896001A0 (da)
IL (1) IL92737A0 (da)
NZ (1) NZ231803A (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0502036T3 (da) * 1989-11-22 1996-05-06 Genentech Inc Latens-associeret peptid og anvendelser herfor
US5168050A (en) * 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
IT1259042B (it) * 1992-01-27 1996-03-11 Mini Ricerca Scient Tecnolog Preparazione di vettori di espressione per la sintesi del polipeptide chiamato fattore osteogenetico op-1 in cellule eucariotiche di spodoptera frugiperda via infezione con baculovirus ricombinante
JP3193050B2 (ja) * 1992-02-12 2001-07-30 ビオファルム ゲゼルシャフト ツア ビオテヒノロ ギッシェン エントヴィックルング フォン ファル マカ ミット ベシュレンクテル ハフツング 新規の増殖／分化因子をコード化するｄｎａ配列
US5847007A (en) * 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1994025588A2 (en) * 1993-04-30 1994-11-10 Biognostik Gesellschaft für Biomolekulare Diagnostik mbH ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
US6521227B1 (en) 1999-11-18 2003-02-18 Peter L. Hudson Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US5994102A (en) * 1994-12-15 1999-11-30 Human Genome Sciences, Inc. Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
AU6277396A (en) 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
EP0856579A1 (en) * 1997-01-31 1998-08-05 BIOGNOSTIK GESELLSCHAFT FÜR BIOMOLEKULARE DIAGNOSTIK mbH An antisense oligonucleotide preparation method
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
EP1117805A2 (en) * 1998-10-07 2001-07-25 STRYKER CORPORATION (a Michigan corporation) Modified tgf-beta superfamily proteins
US6756215B1 (en) * 2000-10-20 2004-06-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Functionalized TGF-β fusion proteins
EP1740609A2 (en) 2004-04-27 2007-01-10 Research Development Foundation Antagonism of tgf-beta superfamily receptor signaling
CN100389120C (zh) * 2005-04-12 2008-05-21 中国人民解放军第三军医大学野战外科研究所 封闭TGF－β1的反义寡核苷酸及其在制备治疗纤维化相关疾病药物中的用途
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
EP0105014B1 (en) * 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Repair of tissue in animals
CA1230591A (en) * 1983-06-03 1987-12-22 Charles A. Frolik PURIFIED TRANSFORMING GROWTH FACTOR-.beta. DERIVED FROM HUMAN PLATELETS AND PLACENTAS
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
US4708948A (en) * 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
EP0169016B2 (en) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Polypeptide cartilage-inducing factors found in bone
IL78197A (en) * 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
KR890700031A (ko) * 1986-11-17 1989-03-02 예안 크라메르 한스 루돌프 하우스 신규한 t-세포 억압 인자의 제조 및 그것의 용도
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
AU630075B2 (en) * 1987-10-06 1992-10-22 Bristol-Myers Squibb Company Cloning and expression of transforming growth factor 2b
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2

Also Published As

Publication number Publication date
IL92737A0 (en) 1990-09-17
FI896001A0 (fi) 1989-12-14
NZ231803A (en) 1992-10-28
AU640115B2 (en) 1993-08-19
EP0676474A1 (en) 1995-10-11
DK638389D0 (da) 1989-12-15
US5221620A (en) 1993-06-22
EP0376785A3 (en) 1992-01-02
CN1045992A (zh) 1990-10-10
AU4683589A (en) 1991-06-21
EP0376785A2 (en) 1990-07-04

Similar Documents

Publication Publication Date Title
DK638389D0 (da) Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne
DK473987A (da) Fremgangsmaade til kontinuert produktion af et oensket heterologt protein i en eukaryotisk vaertcelle, vektor, som tilfoerer denne evne, og celler transformeret med vektoren
DK464087A (da) Haloarylnitril-nedbrydende gen, anvendelsen heraf og celler indeholdende dette
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK163988C (da) 9alfa,11alfa-epoxy-20-spiroxaner og analoge deraf med aaben tetrahydrofuranring e samt deres fremstilling og farmaceutiske praeparater indeholdende dem
DK232690A (da) Nucleinsyrefragmenter, rekombinant-dna-konstruktioner til deres transformation og planter indeholdende dem
NO845223L (no) Flerlag-arkstruktur, fremgangsmaate for dens fremstilling, og beholdere fremstilt derav.
DK650489A (da) Transgene organismer og celler samt fremgangsmaader til fremstilling deraf
DE3782733D1 (de) Sonnenzellensystem.
NO885670D0 (no) Fortilsetning og for som inneholder denne tilsetning.
DK388789A (da) Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
NO875263D0 (no) 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse.
NO874723D0 (no) Forgrende polyoksalkylenblandingspolyestere, fremgangsmaate til deres fremstilling og deres anvendelse.
DK371584A (da) N6-substituerede adenosiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK675387D0 (da) Substituerede phenoxypyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler
NO902291D0 (no) Elektrokjemiske celler.
DK127188D0 (da) L-arylpyrazoler, fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK231089A (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
DK289287D0 (da) 1-phenylalkylimidazol-4- og/eller -5-carboxamider samt deres fremstiling og anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK264688D0 (da) Annelerede (thio)hydantoiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089A (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK675487D0 (da) 2-pyri(mi)dinylthioarylethere, deres fremstilling og anvendelse som plantevaekstregulatorere samt mellemprodukter til fremstillingen

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment